Kwang Dong Pharm Co Ltd in Consumer Health (South Korea)

December 2015 | 2 pages | ID: K75BA2FFE77EN
Euromonitor International Ltd

Abstracts

The company is aiming to reach annual sales of Won1 trillion by 2020 and become a “Total Human Healthcare Brand”. The company is expected to focus on diverse business opportunities, reaching out to acquire more rights to OTC and Rx products, and expanding its product lines of general healthy food products.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Kwang Dong Pharm Co Ltd: Key Facts
  Summary 2 Kwang Dong Pharm Co Ltd: Operational Indicators
Competitive Positioning
  Summary 3 Kwang Dong Pharm Co Ltd: Competitive Position 2015